[{"indications": "Indications\u00a0HIV infection in combination with other\r\nantiretroviral drugs", "name": "DARUNAVIR", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.3 Antiviral drugs", "5.3.1 HIV infection", "Protease inhibitors", "DARUNAVIR"], "cautions": "Cautions\u00a0\n(From Protease inhibitors: British National Formulary)\nProtease inhibitors; also sulfonamide\r\nsensitivity; monitor liver function before\r\nand during treatment; interactions: Appendix 1 (darunavir)Rash\u00a0Mild to moderate rash occurs commonly, usually\r\nwithin the first 4 weeks of therapy and resolves without stopping\r\ntreatment. Severe skin rash (including Stevens-Johnson syndrome and\r\ntoxic epidermal necrolysis) occurs less frequently and may be accompanied\r\nby fever, malaise, arthralgia, myalgia, oral lesions, conjunctivitis,\r\nhepatitis, or eosinophilia; treatment should be stopped\r\nif severe rash develops", "side-effects": "Side-effects\u00a0\n(From Protease inhibitors: British National Formulary)\nProtease inhibitors; also haematemesis, myocardial\r\ninfarction, angina, QT interval prolongation, syncope, bradycardia,\r\ntachycardia, palpitation, hypertension, flushing, peripheral oedema,\r\ndyspnoea, cough, peripheral neuropathy, anxiety, confusion, memory\r\nimpairment, depression, abnormal dreams, convulsions, increased appetite,\r\nweight changes, pyrexia, hypothyroidism, osteoporosis, gynaecomastia,\r\nerectile dysfunction, reduced libido, dysuria, polyuria, nephrolithiasis,\r\nrenal failure, arthralgia, visual disturbances, dry eyes, conjunctival\r\nhyperaemia, rhinorrheoa, throat irritation, dry mouth, stomatisis,\r\nnail discoloration, acne, seborrhoeic dermatitis, eczema, increased\r\nsweating, alopecia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/130111.htm", "doses": ["With low-dose ritonavir, adult over 18 years previously treated with antiretroviral therapy, 600\u00a0mg\r\ntwice daily or (if no resistance to darunavir, if\r\nplasma HIV-RNA concentration less than 100 000 copies/mL, and if CD4\r\ncell count greater than 100 cells \u00d7106/litre)\r\n800\u00a0mg once daily; child 6\u201318 years\r\nsee BNF for Children", "With low-dose ritonavir, adult over 18 years not previously treated with antiretroviral therapy,\r\n800\u00a0mg once daily", "If a dose is more than\r\n6 hours late on the twice daily regimen (or more than 12 hours late\r\non the once daily regimen), the missed dose should not be taken and\r\nthe next dose should be taken at the normal time"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only if potential benefit\r\noutweighs risk\u2014no information available"}]